Supports early-career researchers advancing innovative clinical or translational research in myasthenia gravis, with a focus on strong mentorship and impactful, original science.
Funder: American Academy of Neurology
Due Dates (Anticipated): September 2026
Funding Amounts: $75,000/year for 3 years plus $5,000/year stipend (total $240,000 over 3 years)
Summary: Supports early-career clinical researchers advancing innovative studies in myasthenia gravis with strong mentorship and training.
Key Information: Applicants must be within 7 years of completing residency or PhD and have no more than 30% clinical service during the award.
This award supports young investigators conducting high-quality, patient-oriented, or translational clinical research focused on myasthenia gravis. The program encourages innovative projects that advance the development of treatments or diagnostic tools for neurological diseases. Emphasis is placed on strong mentorship, a robust training environment, and impactful, original research concepts. The award aims to foster the next generation of clinician-scientists and promote diversity, equity, and inclusion in neurology research.